{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T08:57:19Z","timestamp":1775465839223,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T00:00:00Z","timestamp":1774051200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T00:00:00Z","timestamp":1775433600000},"content-version":"vor","delay-in-days":16,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"DOI":"10.1007\/s10875-026-02005-1","type":"journal-article","created":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T06:53:48Z","timestamp":1774076028000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fostamatinib Dual Immunomodulation in Post-Haploidentical HSCT Autoimmune Cytopenia and Autoimmune Hepatitis: A Case Report and Review of Literature"],"prefix":"10.1007","volume":"46","author":[{"given":"Antimo","family":"Tessitore","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debora","family":"Curci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aurelio","family":"Sonzogni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Franzin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Schillani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Flamigni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilda","family":"Paternuosto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Maximova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,21]]},"reference":[{"issue":"9","key":"2005_CR1","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/sj.bmt.1703923","volume":"31","author":"T Ogose","year":"2003","unstructured":"Ogose T, Watanabe T, Suzuya H, Kaneko M, Onishi T, Watanabe H, et al. Autoimmune hepatitis following allogeneic PBSCT from an HLA-matched sibling. Bone Marrow Transpl. 2003;31(9):829\u201332.","journal-title":"Bone Marrow Transpl"},{"key":"2005_CR2","doi-asserted-by":"crossref","unstructured":"Habib S, Nalesnik MA, Ahmad J, BuchBarker D, Shakil AO. Alloimmune hepatitis following peripheral stem cell transplantation. Bone Marrow Transpl. 2007;39:573\u20135.","DOI":"10.1038\/sj.bmt.1705646"},{"issue":"4","key":"2005_CR3","doi-asserted-by":"publisher","first-page":"e27569","DOI":"10.1002\/pbc.27569","volume":"66","author":"CE Neunert","year":"2019","unstructured":"Neunert CE, Despotovic JM. Autoimmune hemolytic anemia and immune thrombocytopenia following hematopoietic stem cell transplant: a critical review of the literature. Pediatr Blood Cancer. 2019;66(4):e27569.","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"2005_CR4","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.bbmt.2013.11.014","volume":"20","author":"M Faraci","year":"2014","unstructured":"Faraci M, Zecca M, Pillon M, Rovelli A, Menconi MC, Ripaldi M, et al. Autoimmune hematological diseases after allogeneic hematopoietic stem cell transplantation in children: an Italian multicenter experience. Biol blood marrow Transpl J Am Soc Blood Marrow Transpl. 2014;20(2):272\u20138.","journal-title":"Biol blood marrow Transpl J Am Soc Blood Marrow Transpl"},{"key":"2005_CR5","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.3389\/fimmu.2020.02017","volume":"11","author":"NP Buxbaum","year":"2020","unstructured":"Buxbaum NP, Pavletic SZ. Autoimmunity following allogeneic hematopoietic stem cell transplantation. Front Immunol. 2020;11:2017.","journal-title":"Front Immunol"},{"key":"2005_CR6","doi-asserted-by":"publisher","first-page":"879994","DOI":"10.3389\/fimmu.2022.879994","volume":"13","author":"E Even-Or","year":"2022","unstructured":"Even-Or E, Schejter YD, NaserEddin A, Zaidman I, Shadur B, Stepensky P. Autoimmune cytopenias post hematopoietic stem cell transplantation in pediatric patients with osteopetrosis and other nonmalignant diseases. Front Immunol. 2022;13:879994.","journal-title":"Front Immunol"},{"issue":"4","key":"2005_CR7","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.bbmt.2017.12.782","volume":"24","author":"MD Kruizinga","year":"2018","unstructured":"Kruizinga MD, van Tol MJD, Bekker V, Netelenbos T, Smiers FJ, Bresters D, et al. Risk factors, treatment, and immune dysregulation in autoimmune cytopenia after allogeneic hematopoietic stem cell transplantation in pediatric patients. Biol blood marrow Transpl J Am Soc Blood Marrow Transpl. 2018;24(4):772\u20138.","journal-title":"Biol blood marrow Transpl J Am Soc Blood Marrow Transpl"},{"issue":"2","key":"2005_CR8","doi-asserted-by":"publisher","first-page":"119","DOI":"10.5045\/br.2017.52.2.119","volume":"52","author":"S Hwang-Bo","year":"2017","unstructured":"Hwang-Bo S, Kim SK, Lee JW, Jang PS, Chung NG, Jeong DC, et al. Treatment and response of autoimmune cytopenia occurring after allogeneic hematopoietic cell transplantation in children. Blood Res. 2017;52(2):119\u201324.","journal-title":"Blood Res"},{"issue":"4","key":"2005_CR9","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/petr.12455","volume":"19","author":"I Ahmed","year":"2015","unstructured":"Ahmed I, Teruya J, Murray-Krezan C, Krance R. The incidence of autoimmune hemolytic anemia in pediatric hematopoietic stem cell recipients post-first and post-second hematopoietic stem cell transplant. Pediatr Transpl. 2015;19(4):391\u20138.","journal-title":"Pediatr Transpl"},{"issue":"10","key":"2005_CR10","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1016\/j.bbmt.2008.07.006","volume":"14","author":"KM Page","year":"2008","unstructured":"Page KM, Mendizabal AM, Prasad VK, Martin PL, Parikh S, Wood S, et al. Posttransplant autoimmune hemolytic anemia and other autoimmune cytopenias are increased in very young infants undergoing unrelated donor umbilical cord blood transplantation. Biol blood marrow Transpl J Am Soc Blood Marrow Transpl. 2008;14(10):1108\u201317.","journal-title":"Biol blood marrow Transpl J Am Soc Blood Marrow Transpl"},{"issue":"1","key":"2005_CR11","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/j.1365-2141.2004.05138.x","volume":"127","author":"TA O\u2019Brien","year":"2004","unstructured":"O\u2019Brien TA, Eastlund T, Peters C, Neglia JP, Defor T, Ramsay NKC, et al. Autoimmune haemolytic anaemia complicating haematopoietic cell transplantation in paediatric patients: high incidence and significant mortality in unrelated donor transplants for non-malignant diseases. Br J Haematol. 2004;127(1):67\u201375.","journal-title":"Br J Haematol"},{"issue":"7","key":"2005_CR12","doi-asserted-by":"publisher","first-page":"e934","DOI":"10.1002\/iid3.934","volume":"11","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Zhang Y, Yu W, Qin Y, He H, Dai F, et al. Immunomodulatory role of spleen tyrosine kinase in chronic inflammatory and autoimmune diseases. Immun Inflamm Dis. 2023;11(7):e934.","journal-title":"Immun Inflamm Dis"},{"issue":"13\u201314","key":"2005_CR13","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.drudis.2010.05.001","volume":"15","author":"M Riccaboni","year":"2010","unstructured":"Riccaboni M, Bianchi I, Petrillo P. Spleen tyrosine kinases: biology, therapeutic targets and drugs. Drug Discov Today. 2010;15(13\u201314):517\u201330.","journal-title":"Drug Discov Today"},{"issue":"12","key":"2005_CR14","doi-asserted-by":"publisher","first-page":"e12130","DOI":"10.1016\/j.heliyon.2022.e12130","volume":"8","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Liu R, Li M, Liu P. The spleen tyrosine kinase (SYK): a crucial therapeutic target for diverse liver diseases. Heliyon. 2022;8(12):e12130.","journal-title":"Heliyon"},{"issue":"3","key":"2005_CR15","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1080\/13543784.2022.2040014","volume":"31","author":"S Tang","year":"2022","unstructured":"Tang S, Yu Q, Ding C. Investigational spleen tyrosine kinase (SYK) inhibitors for the treatment of autoimmune diseases. Expert Opin Investig Drugs. 2022;31(3):291\u2013303.","journal-title":"Expert Opin Investig Drugs"},{"key":"2005_CR16","doi-asserted-by":"publisher","first-page":"581657","DOI":"10.1155\/2014\/581657","volume":"2014","author":"A Khalil","year":"2014","unstructured":"Khalil A, Zaidman I, Bergman R, Elhasid R, Ben-Arush MW. Autoimmune complications after hematopoietic stem cell transplantation in children with nonmalignant disorders. ScientificWorldJournal. 2014;2014:581657.","journal-title":"ScientificWorldJournal"},{"issue":"6","key":"2005_CR17","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/j.bbmt.2020.01.002","volume":"26","author":"U Anurathapan","year":"2020","unstructured":"Anurathapan U, Hongeng S, Pakakasama S, Songdej D, Sirachainan N, Pongphitcha P, et al. Hematopoietic stem cell transplantation for severe thalassemia patients from haploidentical donors using a novel conditioning regimen. Biol blood marrow Transpl J Am Soc Blood Marrow Transpl. 2020;26(6):1106\u201312.","journal-title":"Biol blood marrow Transpl J Am Soc Blood Marrow Transpl"},{"issue":"45","key":"2005_CR18","doi-asserted-by":"publisher","first-page":"79650","DOI":"10.18632\/oncotarget.19021","volume":"8","author":"N Maximova","year":"2017","unstructured":"Maximova N, Gregori M, Boz G, Simeone R, Zanon D, Schillani G, et al. MRI-based evaluation of multiorgan iron overload is a predictor of adverse outcomes in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation. Oncotarget. 2017;8(45):79650\u201361.","journal-title":"Oncotarget"},{"issue":"7","key":"2005_CR19","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1002\/ajh.25125","volume":"93","author":"J Bussel","year":"2018","unstructured":"Bussel J, Arnold DM, Grossbard E, Mayer J, Treli\u0144ski J, Homenda W, et al. Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: results of two phase 3, randomized, placebo-controlled trials. Am J Hematol. 2018;93(7):921\u201330.","journal-title":"Am J Hematol"},{"issue":"6","key":"2005_CR20","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1182\/blood.2024024250","volume":"144","author":"TJ Gonz\u00e1lez-L\u00f3pez","year":"2024","unstructured":"Gonz\u00e1lez-L\u00f3pez TJ, Bermejo-Vega N, Cardesa-Cabrera R, Mart\u00ednez-Robles V, Aguilar-Monserrate G, P\u00e9rez-Segura G, et al. Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice. Blood. 2024;144(6):646\u201356.","journal-title":"Blood"},{"issue":"5","key":"2005_CR21","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1002\/ajh.25444","volume":"94","author":"JB Bussel","year":"2019","unstructured":"Bussel JB, Arnold DM, Boxer MA, Cooper N, Mayer J, Zayed H, et al. Long-term fostamatinib treatment of adults with immune thrombocytopenia during the phase 3 clinical trial program. Am J Hematol. 2019;94(5):546\u201353.","journal-title":"Am J Hematol"},{"key":"2005_CR22","doi-asserted-by":"publisher","first-page":"897","DOI":"10.3389\/fphar.2019.00897","volume":"10","author":"Y Kang","year":"2019","unstructured":"Kang Y, Jiang X, Qin D, Wang L, Yang J, Wu A, et al. Efficacy and safety of multiple dosages of fostamatinib in adult patients with rheumatoid arthritis: a systematic review and meta-analysis. Front Pharmacol. 2019;10:897.","journal-title":"Front Pharmacol"},{"issue":"10","key":"2005_CR23","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1093\/ecco-jcc\/jjv114","volume":"9","author":"G Can","year":"2015","unstructured":"Can G, Ayvaz S, Can H, Demirtas S, Aksit H, Yilmaz B, et al. The syk inhibitor fostamatinib decreases the severity of colonic mucosal damage in a rodent model of colitis. J Crohns Colitis. 2015;9(10):907\u201317.","journal-title":"J Crohns Colitis"},{"issue":"1","key":"2005_CR24","doi-asserted-by":"publisher","first-page":"e14894","DOI":"10.1111\/exd.14894","volume":"33","author":"A Flora","year":"2024","unstructured":"Flora A, Jepsen R, Kozera EK, Woods JA, Cains GD, Radzieta M, et al. Mast cells are upregulated in hidradenitis suppurativa tissue, associated with epithelialized tunnels and normalized by spleen tyrosine kinase antagonism. Exp Dermatol. 2024;33(1):e14894.","journal-title":"Exp Dermatol"},{"key":"2005_CR25","doi-asserted-by":"publisher","first-page":"9757","DOI":"10.2147\/JIR.S486753","volume":"17","author":"R Guo","year":"2024","unstructured":"Guo R, Liao H, Meng Y, Shi X, He Y, Zhu Z, et al. Fostamatinib, a spleen tyrosine kinase inhibitor, exerts anti-inflammatory activity via inhibiting STAT1\/3 signaling pathways. J Inflamm Res. 2024;17:9757\u201371.","journal-title":"J Inflamm Res"},{"issue":"2","key":"2005_CR26","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/ajh.23885","volume":"90","author":"Z Kuzmina","year":"2015","unstructured":"Kuzmina Z, Gounden V, Curtis L, Avila D, Rnp TT, Baruffaldi J, et al. Clinical significance of autoantibodies in a large cohort of patients with chronic graft-versus-host disease defined by NIH criteria. Am J Hematol. 2015;90(2):114\u20139.","journal-title":"Am J Hematol"},{"issue":"6","key":"2005_CR27","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/nri2765","volume":"10","author":"A M\u00f3csai","year":"2010","unstructured":"M\u00f3csai A, Ruland J, Tybulewicz VLJ. The SYK tyrosine kinase: a crucial player in diverse biological functions. Nat Rev Immunol. 2010;10(6):387\u2013402.","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"2005_CR28","doi-asserted-by":"publisher","first-page":"3195","DOI":"10.4049\/jimmunol.168.7.3195","volume":"168","author":"JH Dufour","year":"2002","unstructured":"Dufour JH, Dziejman M, Liu MT, Leung JH, Lane TE, Luster AD. IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. J Immunol. 2002;168(7):3195\u2013204.","journal-title":"J Immunol"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-026-02005-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-026-02005-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-026-02005-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T08:10:21Z","timestamp":1775463021000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-026-02005-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,21]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2005"],"URL":"https:\/\/doi.org\/10.1007\/s10875-026-02005-1","relation":{},"ISSN":["1573-2592"],"issn-type":[{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,21]]},"assertion":[{"value":"13 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"38"}}